Current Progress of COPD Early Detection: Key Points and Novel Strategies

References

• Lamprecht B, Soriano JB, Studnicka M, et al; BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-3
   PubMed Web of Science ®Google Scholar
• Martinez CH, Mannino DM, Jaimes FA, et al. Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality. Ann Am Thorac Soc. 2015;12(12):1788–1795. doi:10.1513/AnnalsATS.201506-388OC
   PubMed Web of Science ®Google Scholar
• Hangaard S, Kronborg T, Hejlesen OK. Characteristics of subjects with undiagnosed COPD based on post-bronchodilator spirometry data. Respir Care. 2019;64(1):63–70. doi:10.4187/respcare.06296
   PubMed Web of Science ®Google Scholar
• Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
   PubMed Web of Science ®Google Scholar
• Schnieders E, Ünal E, Winkler V, et al. Performance of alternative COPD case-finding tools: a systematic review and meta-analysis. Eur Respir Rev. 2021;30(160):200350. doi:10.1183/16000617.0350-2020
   PubMed Web of Science ®Google Scholar
• Global strategy for prevention, diagnosis and management oF COPD: 2023 report; 2023. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed July 14, 2023.
   Google Scholar
• Mangione CM, Barry MJ, Nicholson WK, et al; US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease: US preventive services task force reaffirmation recommendation statement. JAMA. 2022;327(18):1806–1811. doi:10.1001/jama.2022.5692
   PubMed Web of Science ®Google Scholar
• Li HY, Gao TY, Fang W, et al. Global, regional and national burden of chronic obstructive pulmonary disease over a 30-year period: estimates from the 1990 to 2019 Global Burden of Disease Study. Respirology. 2023;28(1):29–36. doi:10.1111/resp.14349
   PubMed Web of Science ®Google Scholar
• Casas Herrera A, Montes de Oca M, López Varela MV, et al. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study. PLoS One. 2016;11(4):e0152266. doi:10.1371/journal.pone.0152266
   PubMed Web of Science ®Google Scholar
• Echazarreta AL, Arias SJ, Del Olmo R, et al; Grupo de estudio EPOC.AR. Prevalence of COPD in 6 urban clusters in Argentina: the EPOC.AR study. Arch Bronconeumol. 2018;54(5):260–269. doi:10.1016/j.arbres.2017.09.018
   PubMed Web of Science ®Google Scholar
• Gershon AS, Thiruchelvam D, Chapman KR, et al; Canadian Respiratory Research Network. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153(6):1336–1346. doi:10.1016/j.chest.2018.01.038
   PubMed Web of Science ®Google Scholar
• Soriano JB, Alfageme I, Miravitlles M, et al. Prevalence and determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021;57(1):61–69. doi:10.1016/j.arbres.2020.07.024
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5(5):426–434. doi:10.1016/S2213-2600(17)30119-4
   PubMed Web of Science ®Google Scholar
• Alhabeeb FF, Whitmore GA, Vandemheen KL, et al. Disease burden in individuals with symptomatic undiagnosed asthma or COPD. Respir Med. 2022;200:106917. doi:10.1016/j.rmed.2022.106917
   PubMed Web of Science ®Google Scholar
• Larsson K, Janson C, Ställberg B, et al. Impact of COPD diagnosis timing on clinical and economic outcomes: the Arctic observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019;14:995–1008. doi:10.2147/COPD.S195382
   PubMed Web of Science ®Google Scholar
• Kostikas K, Price D, Gutzwiller FS, et al. Clinical impact and healthcare resource utilization associated with early versus late COPD diagnosis in patients from UK CPRD database. Int J Chron Obstruct Pulmon Dis. 2020;15:1729–1738. doi:10.2147/COPD.S255414
   PubMed Web of Science ®Google Scholar
• Denguezli M, Daldoul H, Harrabi I, et al. Prevalence and characteristics of undiagnosed COPD in adults 40 years and older - reports from the Tunisian population-based burden of obstructive lung disease study. COPD. 2020;17(5):515–522. doi:10.1080/15412555.2020.1804848
   PubMedGoogle Scholar
• Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2018;19(1):26. doi:10.1186/s12931-018-0731-1
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhong NS, Li X, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377(10):923–935. doi:10.1056/NEJMoa1700228
   PubMed Web of Science ®Google Scholar
• Scanlon PD, Connett JE, Waller LA, et al; Lung Health Study Research Group. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The lung health study. Am J Respir Crit Care Med. 2000;161(2 Pt 1):381–390. doi:10.1164/ajrccm.161.2.9901044
   PubMed Web of Science ®Google Scholar
• Jácome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care. 2014;59(4):588–594. doi:10.4187/respcare.02742
   PubMed Web of Science ®Google Scholar
• Rugbjerg M, Iepsen UW, Jørgensen KJ, Lange P. Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses. Int J Chron Obstruct Pulmon Dis. 2015;10:791–801. doi:10.2147/COPD.S78607
   PubMed Web of Science ®Google Scholar
• Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008;134(1):38–45. doi:10.1378/chest.08-0013
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Mahringer A, Soriano JB, Kaiser B, Buist AS, Studnicka M. Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. Prim Care Respir J. 2013;22(2):195–200. doi:10.4104/pcrj.2013.00032
   PubMedGoogle Scholar
• Heffler E, Crimi C, Mancuso S, et al. Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients. Respir Med. 2018;142:48–52. doi:10.1016/j.rmed.2018.07.015
   PubMed Web of Science ®Google Scholar
• Hangaard S, Helle T, Nielsen C, Hejlesen OK. Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med. 2017;129:63–84. doi:10.1016/j.rmed.2017.05.015
   PubMed Web of Science ®Google Scholar
• Vanjare N, Chhowala S, Madas S, Kodgule R, Gogtay J, Salvi S. Use of spirometry among chest physicians and primary care physicians in India. NPJ Prim Care Respir Med. 2016;26:16036. doi:10.1038/npjpcrm.2016.36
   PubMed Web of Science ®Google Scholar
• Hu G, Zhou Y, Tian J, et al. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010;138(1):20–31. doi:10.1378/chest.08-2114
   PubMed Web of Science ®Google Scholar
• Doiron D, de Hoogh K, Probst-Hensch N, et al. Air pollution, lung function and COPD: results from the population-based UK Biobank study. Eur Respir J. 2019;54:1802140. doi:10.1183/13993003.02140-2018
   PubMed Web of Science ®Google Scholar
• Agusti A, Faner R. Lung function trajectories in health and disease. Lancet Respir Med. 2019;7(4):358–364. doi:10.1016/S2213-2600(18)30529-0
   PubMed Web of Science ®Google Scholar
• Çolak Y, Nordestgaard BG, Vestbo J, Lange P, Afzal S. Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study. Eur Respir J. 2021;57:2004055. doi:10.1183/13993003.04055-2020
   PubMed Web of Science ®Google Scholar
• Stern DA, Morgan WJ, Wright AL, Guerra S, Martinez FD. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet. 2007;370:758–764. doi:10.1016/S0140-6736(07)61379-8
   PubMed Web of Science ®Google Scholar
• Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of CI. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175:1539–1549. doi:10.1001/jamainternmed.2015.2735
   PubMed Web of Science ®Google Scholar
• Minas M, Hatzoglou C, Karetsi E, et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J. 2010;19(4):363–370. doi:10.4104/pcrj.2010.00034
   PubMedGoogle Scholar
• Grigsby M, Siddharthan T, Chowdhury MA, et al. Socioeconomic status and COPD among low- and middle-income countries. Int J Chron Obstruct Pulmon Dis. 2016;11:2497–2507. doi:10.2147/COPD.S111145
   PubMed Web of Science ®Google Scholar
• Keranis E, Makris D, Rodopoulou P, et al. Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial. Eur Respir J. 2010;36:774–780. doi:10.1183/09031936.00113809
   PubMed Web of Science ®Google Scholar
• Seyedrezazadeh E, Moghaddam MP, Ansarin K, et al. Dietary factors and risk of chronic obstructive pulmonary disease: a systemic review and meta-analysis. Tanaffos. 2019;18(4):294–309.
   PubMedGoogle Scholar
• Perret JL, Walters H, Johns D, et al. Mother’s smoking and complex lung function of offspring in middle age: a cohort study from childhood. Respirology. 2016;21:911–919. doi:10.1111/resp.12750
   PubMed Web of Science ®Google Scholar
• He Y, Jiang B, Li LS, et al. Secondhand smoke exposure predicted COPD and other tobacco-related mortality in a 17-year cohort study in China. Chest. 2012;142:909–918. doi:10.1378/chest.11-2884
   PubMed Web of Science ®Google Scholar
• Lambe T, Adab P, Jordan RE, et al. Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care. Thorax. 2019;74(8):730–739. doi:10.1136/thoraxjnl-2018-212148
   PubMed Web of Science ®Google Scholar
• Haroon SM, Jordan RE, O’Beirne-Elliman J, Adab P. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2015;25:15056. doi:10.1038/npjpcrm.2015.56
   PubMed Web of Science ®Google Scholar
• Jordan RE, Adab P, Sitch A, et al. Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial. Lancet Respir Med. 2016;4(9):720–730. doi:10.1016/S2213-2600(16)30149-7
   PubMed Web of Science ®Google Scholar
• Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J. 2011;20(2):190–198. doi:10.4104/pcrj.2011.00040
   PubMedGoogle Scholar
• Thorn J, Tilling B, Lisspers K, Jörgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012;21(2):159–166. doi:10.4104/pcrj.2011.00104
   PubMedGoogle Scholar
• van den Bemt L, Wouters BC, Grootens J, Denis J, Poels PJ, Schermer TR. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study. NPJ Prim Care Respir Med. 2014;24:14033. doi:10.1038/npjpcrm.2014.33
   PubMed Web of Science ®Google Scholar
• Represas-Represas C, Fernández-Villar A, Ruano-Raviña A, Priegue-Carrera A, Botana-Rial M. study group of “validity of COPD-6 in non-specialized healthcare settings”. Screening for chronic obstructive pulmonary disease: validity and reliability of a portable device in non-specialized healthcare settings. PLoS One. 2016;11(1):e0145571. doi:10.1371/journal.pone.0145571
   PubMed Web of Science ®Google Scholar
• Labor M, Vrbica Ž, Gudelj I, Labor S, Plavec D. Diagnostic accuracy of a pocket screening spirometer in diagnosing chronic obstructive pulmonary disease in general practice: a cross sectional validation study using tertiary care as a reference. BMC Fam Pract. 2016;17(1):112. doi:10.1186/s12875-016-0518-8
   PubMedGoogle Scholar
• Kim JK, Lee CM, Park JY, et al. Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry. Medicine. 2016;95(50):e5683. doi:10.1097/MD.0000000000005683
   PubMed Web of Science ®Google Scholar
• Llordés M, Zurdo E, Jaén Á, Vázquez I, Pastrana L, Miravitlles M. Which is the best screening strategy for COPD among smokers in primary care? COPD. 2017;14(1):43–51. doi:10.1080/15412555.2016.1239703
   PubMedGoogle Scholar
• Hidalgo Sierra V, Hernández Mezquita MÁ, Palomo Cobos L, et al. Usefulness of the piko-6 portable device for early COPD detection in primary care. Arch Bronconeumol. 2018;54(9):460–466. doi:10.1016/j.arbres.2018.04.015
   PubMed Web of Science ®Google Scholar
• Ronaldson SJ, Dyson L, Clark L, et al; DOC study team. Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease: the DOC study. J Eval Clin Pract. 2018;24(3):487–495. doi:10.1111/jep.12896
   PubMed Web of Science ®Google Scholar
• Dickens AP, Fitzmaurice DA, Adab P, et al. Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care. NPJ Prim Care Respir Med. 2020;30(1):2. doi:10.1038/s41533-019-0158-2
   PubMed Web of Science ®Google Scholar
• Fujita M, Nagashima K, Takahashi S, Suzuki K, Fujisawa T, Hata A. Handheld flow meter improves COPD detectability regardless of using a conventional questionnaire: a split-sample validation study. Respirology. 2020;25(2):191–197. doi:10.1111/resp.13602
   PubMed Web of Science ®Google Scholar
• Lin CH, Cheng SL, Wang HC, et al. Novel app-based portable spirometer for the early detection of COPD. Diagnostics. 2021;11(5):785. doi:10.3390/diagnostics11050785
   Web of Science ®Google Scholar
• Lopez Varela MV, Montes de Oca M, Wehrmeister FC, Rodriguez C, Ramirez L, Menezes A. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population. Int J Chron Obstruct Pulmon Dis. 2019;14:1901–1911. doi:10.2147/COPD.S206250
   PubMed Web of Science ®Google Scholar
• Spyratos D, Haidich AB, Chloros D, Michalopoulou D, Sichletidis L. Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care. Respiration. 2017;93(2):83–89. doi:10.1159/000453586
   PubMed Web of Science ®Google Scholar
• López Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V; PUMA Team. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: the PUMA study. Respirology. 2016;21(7):1227–1234. doi:10.1111/resp.12834
   PubMed Web of Science ®Google Scholar
• Stanley AJ, Hasan I, Crockett AJ, van Schayck OC, Zwar NA. COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24:14024. doi:10.1038/npjpcrm.2014.24
   PubMed Web of Science ®Google Scholar
• Preteroti M, Whitmore GA, Vandemheen KL, et al. Population-based case-finding to identify subjects with undiagnosed asthma or COPD. Eur Respir J. 2020;55(6):2000024. doi:10.1183/13993003.00024-2020
   PubMed Web of Science ®Google Scholar
• Quezada WA, Whippo BA, Jellen PA, et al; High-Risk-COPD Screening Study Group. How well does CAPTURE translate?: an exploratory analysis of a COPD case-finding method for Spanish-speaking patients. Chest. 2017;152(4):761–770. doi:10.1016/j.chest.2017.03.047
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Mannino D, Leidy NK, et al; High-Risk-COPD Screening Study Group. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(6):748–756. doi:10.1164/rccm.201603-0622OC
   PubMed Web of Science ®Google Scholar
• Chen CZ, Sheu CC, Cheng SL, et al. Performance and clinical utility of various chronic obstructive pulmonary disease case-finding tools. Int J Chron Obstruct Pulmon Dis. 2021;16:3405–3415. doi:10.2147/COPD.S339340
   PubMed Web of Science ®Google Scholar
• Tanino A, Kawamura T, Hamaguchi M, et al. A novel model-based questionnaire based on low-dose CT screening data for chronic obstructive pulmonary disease diagnosis in Shimane, Japan. Int J Chron Obstruct Pulmon Dis. 2021;16:1823–1833. doi:10.2147/COPD.S308922
   PubMed Web of Science ®Google Scholar
• Soriano JB, Molina J, Miravitlles M. Combining case-finding methods for COPD in primary care: a large, two-stage design study. Int J Tuberc Lung Dis. 2018;22(1):106–111. doi:10.5588/ijtld.17.0334
   PubMed Web of Science ®Google Scholar
• Siddharthan T, Wosu AC, Pollard SL, et al; LiNK Cohort Study Investigators. A novel case-finding instrument for chronic obstructive pulmonary disease in low- and middle-income country settings. Int J Chron Obstruct Pulmon Dis. 2020;15:2769–2777. doi:10.2147/COPD.S268076
   PubMed Web of Science ®Google Scholar
• Divo MJ, Marin JM, Casanova C, et al; BODE Collaborative Group. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease. Respir Res. 2022;23(1):267. doi:10.1186/s12931-022-02191-7
   PubMed Web of Science ®Google Scholar
• Morice AH, Celli B, Kesten S, Lystig T, Tashkin D, Decramer M. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med. 2010;104(11):1659–1667. doi:10.1016/j.rmed.2010.07.016
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Lange P, Vestbo J. Importance of early COPD in young adults for development of clinical COPD: findings from the Copenhagen general population study. Am J Respir Crit Care Med. 2021;203(10):1245–1256. doi:10.1164/rccm.202003-0532OC
   PubMed Web of Science ®Google Scholar
• Cosío BG, Pascual-Guardia S, Borras-Santos A, et al. Phenotypic characterisation of early COPD: a prospective case-control study. ERJ Open Res. 2020;6(4):00047–2020. doi:10.1183/23120541.00047-2020
   PubMedGoogle Scholar
• Khalid F, Wang W, Mannino D, Diaz AA. Prevalence and population attributable risk for early chronic obstructive pulmonary disease in U.S. Hispanic/Latino individuals. Ann Am Thorac Soc. 2022;19(3):363–371. doi:10.1513/AnnalsATS.202103-253OC
   PubMed Web of Science ®Google Scholar
• Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921–972. doi:10.1016/S0140-6736(22)01273-9
   PubMed Web of Science ®Google Scholar
• Du Plessis E, Swart F, Maree D, et al. The utility of hand-held mobile spirometer technology in a resource-constrained setting. S Afr Med J. 2019;109(4):219–222. doi:10.7196/SAMJ.2019.v109i4.13845
   PubMed Web of Science ®Google Scholar
• Jankowski P, Górska K, Mycroft K, et al. The use of a mobile spirometry with a feedback quality assessment in primary care setting - A nationwide cross-sectional feasibility study. Respir Med. 2021;184:106472. doi:10.1016/j.rmed.2021.106472
   PubMed Web of Science ®Google Scholar
• Ramos Hernández C, Núñez Fernández M, Pallares Sanmartín A, et al. Validation of the portable air-smart spirometer. PLoS One. 2018;13(2):e0192789. doi:10.1371/journal.pone.0192789
   PubMed Web of Science ®Google Scholar
• Boros PW, Maciejewski A, Nowicki MM, Wesołowski S. Comparability of portable and desktop spirometry: a randomized, parallel assignment, open-label clinical trial. Adv Respir Med. 2022;90:60–67. doi:10.5603/ARM.a2022.0013
   Web of Science ®Google Scholar
• Wasilewska E, Sobierajska-Rek A, Małgorzewicz S, Soliński M, Szalewska D, Jassem E. Is it possible to have home E-monitoring of pulmonary function in our patients with Duchenne muscular dystrophy in the COVID-19 pandemic?-A one center pilot study. Int J Environ Res Public Health. 2021;18(17):8967. doi:10.3390/ijerph18178967
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang Y, Wen Q, et al. Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis. Ann Med. 2021;53(1):1198–1206. doi:10.1080/07853890.2021.1949486
   PubMed Web of Science ®Google Scholar
• Bastidas-Goyes AR, Cardozo-Niñoz AO, Quintero-Muñoz E, López-Gómez KA, Suárez-Escobar LP, Hernández-Santos LE. Clinical questionnaires for chronic obstructive pulmonary disease diagnosis: a systematic review and meta-analysis. Revista de la Facultad de Medicina. 2021;69(1):e204.
   Google Scholar
• Huynh C, Whitmore GA, Vandemheen KL, et al. Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPD. Eur Respir J. 2022;60(3):2103243. doi:10.1183/13993003.03243-2021
   PubMed Web of Science ®Google Scholar
• Mapel DW, Petersen H, Roberts MH, et al. Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care. 2010;16:505–512.
   PubMed Web of Science ®Google Scholar
• Kotz D, Simpson CR, Viechtbauer W, et al. Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD. NPJ Prim Care Respir Med. 2014;24:14011. doi:10.1038/npjpcrm.2014.11
   PubMed Web of Science ®Google Scholar
• Haroon S, Adab P, Riley RD, et al. Predicting risk of COPD in primary care: development and validation of a clinical risk score. BMJ Open Respir Res. 2015;2:e000060. doi:10.1136/bmjresp-2014-000060
   PubMedGoogle Scholar
• Smidth M, Sokolowski I, Kaersvang L, et al. Developing an algorithm to identify people with Chronic Obstructive Pulmonary Disease (COPD) using administrative data. BMC Med Inform Decis. 2012;12. doi:10.1186/1472-6947-12-38
   PubMed Web of Science ®Google Scholar
• Haroon S, Adab P, Riley RD, Fitzmaurice D, Jordan RE. Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score. Eur Respir J. 2017;49(6):1602191. doi:10.1183/13993003.02191-2016
   PubMed Web of Science ®Google Scholar
• Su KC, Ko HK, Chou KT, et al. An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study. NPJ Prim Care Respir Med. 2019;29(1):22. doi:10.1038/s41533-019-0135-9
   PubMedGoogle Scholar
• Siddharthan T, Pollard SL, Quaderi SA, et al; GECo Study Investigators. Discriminative accuracy of chronic obstructive pulmonary disease screening instruments in 3 low- and middle-income country settings. JAMA. 2022;327(2):151–160. doi:10.1001/jama.2021.23065
   PubMed Web of Science ®Google Scholar